Clinical Trial Update: DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer

View source ↗

Summary

The DECAMP-2 trial is a screening study evaluating individuals with early-stage lung cancer or at high risk for developing lung cancer; the study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Boston University | Conditions: Pulmonary Disease | Status: ACTIVE_NOT_RECRUITING